MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$20,161,099
(1.23%↑ Y/Y)
Loss before income
tax
-$19,299,981
(2.89%↑ Y/Y)
Income tax
$861,118
(60.41%↑ Y/Y)
Interest income, net
$244,394
(-31.56%↓ Y/Y)
Loss from operations
-$18,710,702
(8.06%↑ Y/Y)
Foreign exchange (loss)
gain, net
-$833,673
(-799.86%↓ Y/Y)
Total operating
expenses
$18,710,702
(-8.06%↓ Y/Y)
Research and development
$10,212,782
(-5.36%↓ Y/Y)
General and
administrative
$8,497,920
(-11.11%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Gain Therapeutics, Inc. (GANX)
Gain Therapeutics, Inc. (GANX)